TAF7 is a critical subunit of the TFIID transcription factor complex that plays essential roles in RNA polymerase II-mediated transcription initiation and regulation. As part of TFIID, TAF7 forms a promoter DNA-binding subcomplex with TAF1 and TAF2, contributing to the recognition and binding of promoters with or without TATA boxes 1. TAF7 functions as a key regulator of transcriptional activity through its interaction with TAF1, where it normally inhibits TAF1's histone acetyltransferase (HAT) activity 2. However, when TAF7 is phosphorylated at serine-264 by TAF1 kinase, it is released from this inhibitory interaction, leading to enhanced TAF1 HAT activity and increased transcription of cell cycle genes including cyclin D1 and cyclin A 2. TAF7 can also be post-translationally modified by methylation at K5 and K300 sites by SETD7, which stabilizes the protein and enhances its transcriptional activity 3. The protein demonstrates clinical significance in cancer biology, being upregulated in clear cell renal cell carcinoma and glioblastoma, where it promotes cell proliferation and migration through transcriptional activation of cell cycle regulators like CCNA2 34. Additionally, TAF7 participates in developmental processes and appears to play a role in male germ cell function and spermatogenesis 56.